Skip to main content
    A

    AMN Healthcare Services Inc (AMN)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $38.12
    -1.52 (-3.83%)

    Market Cap: $1.47B

    Last updated: Nov 17, 2026 at 4:22 PM ET

    AMN Healthcare Services Inc (AMN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    AMN Healthcare Services (AMN) has a market cap of $1.47B and an enterprise value of $1.95B. Revenue grew 29.45% over the last 12 months from the 12 months before. Its trailing P/E of 9.0x is below its 10-year median of 14.5x.

    Total Valuation

    Enterprise value is 33.24% above the market cap, as debt exceeds cash.

    Market Cap$1.47B
    Enterprise Value$1.95B
    Latest price (Nov 17, 2026)$38.12

    Key Dates

    The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 17, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.23% in the quarter ended Sep 30, 2026 and grew 1.18% a year over 2 years.

    Shares Outstanding39.11M
    Shares Change (YoY)+1.27%
    Shares Change (QoQ)+0.23%
    Share Count Growth (2Y CAGR)+1.18%

    Valuation Ratios

    Sales and book value multiples are 0.4x and 1.9x. Its year-end P/E ranged from 7.2x to 19.8x from 2016 to 2025.

    P/E Ratio9.0x
    Forward P/E9.9x
    P/S Ratio0.4x
    Forward P/S0.4x
    P/B Ratio1.9x
    P/FCF Ratio4.6x
    P/OCF Ratio4.1x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 5.8x EBITDA and 6.0x free cash flow.

    EV / Earnings17.9x
    EV / Sales0.6x
    EV / EBITDA5.8x
    EV / EBIT9.6x
    EV / FCF6.0x

    Price Statistics

    The stock is up 139.90% over 52 weeks and trades 1.80% below its 50-day average.

    Beta (1Y)0.56
    52-Week Change+139.90%
    1-Month Change-5.88%
    3-Month Change+7.93%
    6-Month Change+41.60%
    5-Year Change-52.27%
    10-Year Change+43.63%
    Total Return (1Y)+139.90%
    Total Return (3Y CAGR)-16.98%
    Total Return (5Y CAGR)-19.99%
    Return vs SPY (1Y)+127.74%
    Max Drawdown (1Y)-26.14%
    Max Drawdown (3Y)-80.92%
    Sharpe Ratio (1Y)1.28
    Correlation with SPY (1Y)0.11
    50-Day Average$38.82
    200-Day Average$29.70
    52-Week Range$14.97 to $49.62
    RSI (14 Days)43.0
    Average Volume (20 Days)936.66K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.21x current liabilities, and total debt is 0.96x shareholder equity.

    Current Ratio1.21x
    Quick Ratio1.21x
    Debt / Equity0.96x
    Debt / EBITDA2.18x
    Debt / FCF2.27x
    Interest Coverage6.08x

    Returns and Efficiency

    Return on invested capital is 8.68% over the last 12 months, against a 5-year average of 9.15%.

    Return on Equity (ROE)14.07%
    Return on Assets (ROA)4.75%
    Return on Invested Capital (ROIC)8.68%
    Return on Capital Employed (ROCE)12.46%
    ROE (5Y Average)12.07%
    ROA (5Y Average)4.48%
    ROIC (5Y Average)9.15%
    Asset Turnover1.59x
    Receivables Turnover7.95x

    Taxes

    Income tax took 35.64% of pretax income over the last 12 months.

    Income Tax (TTM)$60.36M
    Effective Tax Rate35.64%

    Scores

    AMN has an Altman Z-Score of 3.30, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score3.30
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $3.52B over the last 12 months.

    Revenue$3.52B
    Revenue Growth (YoY)+29.45%
    Gross Profit$998.97M
    Operating Income$202.71M
    Pretax Income$169.38M
    Net Income$109.02M
    EBITDA$341.52M
    EBIT$202.71M
    Reported EPS (TTM)$4.25

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 33.84% of the $2.29B in total assets.

    Cash and Equivalents$255.98M
    Total Debt$743.37M
    Net Debt$487.39M
    Net Debt Per Share$12.46
    Working Capital$137.95M
    Shareholder Equity$775.01M
    Book Value Per Share$19.82
    Tangible Book Value-$217.80M
    Total Assets$2.29B
    Total Liabilities$1.52B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $33.53M of capital spending, operating cash flow left $327.03M of free cash flow.

    Operating Cash Flow$360.57M
    Capital Expenditures$33.53M
    Free Cash Flow$327.03M
    FCF Per Share$8.44
    Depreciation and Amortization$138.81M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 5.76%, against a 5-year average of 5.56%.

    Gross Margin28.40%
    Operating Margin5.76%
    Pretax Margin4.82%
    Net Margin3.10%
    EBITDA Margin9.71%
    EBIT Margin5.76%
    FCF Margin9.30%
    Gross Margin (5Y Average)31.55%
    Operating Margin (5Y Average)5.56%
    Net Margin (5Y Average)2.76%

    Growth

    Revenue fell 19.55% a year over 3 years, and EPS 51.40% a year.

    Revenue Growth (3Y CAGR)-19.55%
    Revenue Growth (5Y CAGR)+2.67%
    EPS Growth (3Y CAGR)-51.40%
    EPS Growth (5Y CAGR)-16.94%
    FCF Growth (3Y CAGR)-26.04%
    FCF Growth (5Y CAGR)+1.31%
    Book Value Per Share Growth (2Y CAGR)-12.76%

    Revenue and profit by year

    Dividends and Yields

    AMN does not pay a dividend. Its free cash flow yield is 21.94%.

    Earnings Yield11.11%
    FCF Yield21.94%
    Buyback Yield0.56%
    Shareholder Yield0.56%

    Peer Position

    Against 9 similar companies, AMN has the 9th highest P/E.

    P/E Ratio9.0x vs 28.6x median
    P/S Ratio0.4x vs 1.3x median
    ROIC8.68% vs 8.73% median
    Revenue Growth (Trailing 4 Quarters, YoY)+29.45% vs +4.85% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -0.21% and EPS growth at -16.84% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-0.21%
    EPS Growth Forecast (2Y CAGR)-16.84%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About AMN

    What is AMN's market cap?

    AMN Healthcare Services has a market cap of $1.47B. Its enterprise value, which adds debt and subtracts cash, is $1.95B.

    What is AMN's P/E ratio?

    AMN Healthcare Services has a trailing P/E ratio of 9.0x and a forward P/E of 9.9x.

    How many shares of AMN are outstanding?

    AMN Healthcare Services has 39.11M shares outstanding. The count is up 1.27% from a year earlier.

    Does AMN pay a dividend?

    No. AMN Healthcare Services does not pay a dividend.

    How much debt does AMN have?

    AMN Healthcare Services has $743.37M of total debt and $255.98M of cash and equivalents, a net debt position of $487.39M.